that specifically targets the alpha(5)beta(1) integrin which is over-expressed in a variety of cancer cells and on tumor vasculature
| Story Title | Content type | Authored by | Authored on |
|---|---|---|---|
| Bioengineering Seminar Series | Event | Colly Mitchell |
Sunday, January 18, 2026
| Story Title | Content type | Authored by | Authored on |
|---|---|---|---|
| Bioengineering Seminar Series | Event | Colly Mitchell |